H1-receptor Antagonists
A:
H1-receptor Antagonists |
|||
- The term
antihistamine refers primarily to the classic H1-receptor
blockers. The new classification of H1-receptor blockers: first-, second- and
Third-generation. |
|||
First
Generation (Sedating Antihistamines) |
|||
-The older first-generation
drugs are still widely used because they are effective and inexpensive. Most of
these drugs penetrate the CNS (lipophilic) and cause sedation. - Short
duration of action (4 to 6 hours). - Some of these drugs have another actions
in addition of Hi-blockers e.g. Anticholinergic, Antiemetic, Antiserotonin
and local anesthetic effects. |
|||
Chlorpheniramine
(Anallerge®) |
Brompheniramine
(VaZol®) |
||
Hydroxyzine
(Atarax®) |
Triprolidine
(Actifed®) |
Dimethindene
(Fenistil®) |
|
Clemastine
(Tavegyl®) |
Pheniramine
(Avil®) |
Mequitazine
(Primalan®) |
|
- Chlorpheniramine,
Triprolidine ; slight sedation, common component of cold medication. - Hydroxyzine
: marked sedation. - Brompheniramine
, Dimethindene , Clemastine , Pheniramine
and Mequitazine : slight sedation. |
|||
Diphenhydramine
(Dramenex®) |
Cyclizine
(Emetrex®) |
Doxylamine
(Donormyl®) |
|
Dimenhydrinate
(Dramamine®) |
Meclizine
(Navidoxine®) |
Promethazine
(Phenergan®) |
|
- Diphenhydramine
, Dimenhydrinate, Cyclizine, Meclizine, Doxylamine and Promethazine are the most effective agents for prevention of the
symptoms of motion sickness and vertigo (prevent nausea and vomiting). The antiemetic
action; due to block central H1 and M1 muscarinic receptors. -
Diphenhydramine, Dimenhydrinate and Promethazine; marked sedation. - Cyclizine
and Meclizine; slight sedation. - Doxylamine;
strong sedation, used in the treatment of insomnia. |
|||
Cyproheptadine
(Triactin®) |
|||
-
Cyproheptadine also acts as a serotonin antagonist on the appetite center and
is sometimes used off-label as an appetite stimulant. |
|||
Second
Generation (Non-sedating Antihistamines) |
|||
- The newer second-generation
drugs are expensive. - They are made polar mainly by adding carboxyl groups,
the second-generation agents don't pass the BBB, causing less CNS sedation. -
Long duration of action (12 to 24 hours). - More selective for H1-receptors
(no anticholinergic, no antiemetic and no antiserotonin activity). |
|||
Cetirizine
(Zyrtec®) |
Loratadine
(Claritin®) |
Acrivastine
(Semprex®) |
|
Ebastine
(Kestine®) |
Mizolastine
(Zolim®) |
||
-
Cetirizine is a partially sedating
second-generation agents. - Loratadine,
Acrivastine, Ebastine, Mizolastine; show the least sedation. |
|||
Alcaftadine (Lastacaft®) |
Bepotastine (Talion®) |
||
Emedastine (Emadine®) |
Azelastine (Azelast®) |
Olopatadine (Patanol®) |
|
[Ophthalmic
Antihistamines] Ketotifen ,
Alcaftadine , Bepotastine ,Emedastine , Azelastine and Olopatadine : ophthalmic formulations
and used for the treatment of allergic conjunctivitis. - Azelastine
and Olopatadine à
have intranasal formulations, Ketotifenà
has oral formulations. - Azelastine
and Ketotifen; have mast cell stabilizing effects in addition to their H1-blocking effects. |
|||
Third Generation (Non-sedating Antihistamines) |
||
- Third-generation are the
active enantiomer (Levocetirizine) or metabolite derivatives (Desloratadine
& Fexofenadine) of second-generation drugs intended to have
increased efficacy with fewer adverse
drug reactions. - They are more expensive than
second-generation. - Don't pass the BBB, causing no
or less CNS sedation than second-generation. - Long duration of action (24
hours). - Pure selective for
H1-receptors. |
||
Levocetirizine (Allear) |
Desloratadine
(Aerius) |
Fexofenadine (Telfast) |
- Levocetirizine
is the active enantiomer of Cetirizine, and cause partially sedation. - Desloratadine
, Fexofenadine, are the least antihistamines sedation. -
Desloratadine is an active metabolite of Loratadine. -
Fexofenadine is an active metabolite of Terfenadine. - Terfenadine (Prodrug) is metabolized to Fexofenadine
(Active drug), liver microsomal enzyme inhibitors (e.g. Erythromycin) inhibit
this metabolism, lead to increase concentration of Terfenadine in the blood à
Block K+ channels in the heart à
cardiac arrhythmia (QT interval prolongation). (No
cardiotoxicity with fexofenadine). |
Pharmacodynamics
1) Sedation:
- A common effect of
first-generation antihistaminic is sedation, but the intensity of this effect
varies
among chemical
structure and lipophilicity. This effect make them useful as "sleep
aid".
- At very high toxic
dose, marked stimulation, agitation and even convulsions
may produce coma.
- Second-generation
have little or no sedation or stimulant action.
2) Antinausea and
antiemetic actions:
- Several
first-generation antihistaminic have significant activity in prevention motion
sickness.
- The antiemetic
effects are not fully understood, but its central block H1 and M1 receptors
properties
are partially
responsible and it may affect the medullary chemoreceptor trigger zone (CTZ).
3) Antiparkinsonism
effects:
- Some of
first-generation antihistaminic especially Diphenhydramine, have significant
acute
suppressant
effects on certain the extrapyramidal symptoms associated with antipsychotic
drugs (it
given parenterally).
4) Anticholinoceptor
actions:
Many first-generation have antihistaminic especially Diphenhydramine, Clemastine, Dimenhydrinate Doxylamine
have significant atropine-like effects (dry mouth, urinary retention and
blurred vision).
5)
Adrenoceptor-blocking actions:
- α1-adrenoreceptor
blocking effects can demonstrated for many first-generation antihistaminic
especially
Promethazine, this action may cause orthostatic hypotension.
6) Serotonin-blocking
action:
- Strong blocking
effects at serotonin receptors have been demonstrated for some first-generation
antihistaminic especially Cyproheptadine, it is used off-label as an appetite
stimulant.
7) Local anesthesia:
Several first-generation antihistaminic are potent
local anesthetics especially Diphenhydramine and Promethazine they block Na+
channels in excitable membranes.
Therapeutic
uses
1)
Allergic Reactions: Antihistaminic agents are the first drugs used to prevent
or treat symptoms of allergic reaction.
- Allergic rhinitis (hay fever): Antihistaminic agents are second line drugs
after glucocorticoids administrated by nasal spray.
- Urticaria:
Antihistaminic agents are first line (given before exposure). -
Second-generation antihistaminic more preferred in chronic urticaria.
- Atopic dermatitis: First-generation antihistaminic such as
Diphenhydramine used mostly due to sedative effects (decrease itching
awareness).
- Bronchial asthma and angioedema: Antihistaminic agents are
largely ineffective alone in bronchial asthma and angioedema due to in asthma
and angioedema à increase
release of histamine and other mediator antihistaminic agents block only
histamine action.
2) Motion
Sickness and Vestibular Disturbance:
- Scopolamine and certain first-generation antihistaminic
especially Diphenhydramine and Promethazine are the most effective agents
available for prevention of motion sickness.
- Cyclizine and Meclizine also have significant activity in
prevention of motion sickness and are less sedation than Diphenhydramine .
3) Nausea and Vomiting of Pregnancy (NVP):
- Meclizine, Cyclizine and Doxylamine are combined with
Vitamin B6 to control of nausea and vomiting during pregnancy.
4) Somnifacient (Hypnotic):
- First-generation antihistaminic may use as sleep aid in
insomnia especially Doxylamine and Diphenhydramine (Strong sedative).
CONTRAINDICATION
First-generation antihistaminic is contraindicated in the
treatment of individuals working in jobs in which wakefulness is critical such
as drivers and worker jn dangerous machines.
Toxicity
Systemic Acute Toxicity with first-generation antihistaminic
is relatively common, especially in young children, including hallucinations,
excitement, ataxia, and convulsions. So. (Emetrex Ampoule) is NOT
recommended in CHILDREN younger than 6 years to prevent von (serotonin
antagonists such as Ondansetron is safer).
Drug interaction
First generation antihistaminic interact;
- With anxiolytic and hypnotic drugs e.g. Benzodiazepines
(BDZS) à
increase sedative effect (Additive effect).
- With MAO inhibitors à
increase anticholinergic effects.
- With cholinesterase inhibitors used in Alzheimer's disease
decrease (Donepezil, Rivastigmine and galantamine) cholinergic effects.
Second generation Terfenadine interact;
- With Liver microsomal enzyme inhibitors (e.g. Erythromycin
and Ketoconazole) inhibit metabolism of Terfenadine, lead to increase
concentration of Terfenadine in the blood à
Block K+ channels in the heart cardiac arrhythmia (QT interval prolongation).
No comments:
Post a Comment